{
  "docId": "019de071-f0b8-737f-9ff6-e8b6f7a1e960",
  "docSlug": "213575480fcc7466657230c6a0d87626",
  "documentTitle": "23andMe | Investor Day Presentation Deck | 78 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 54,
  "pageCount": 78,
  "prevPage": 53,
  "nextPage": 55,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-f0b8-737f-9ff6-e8b6f7a1e960/54",
  "deckHref": "/decks/019de071-f0b8-737f-9ff6-e8b6f7a1e960",
  "deckJsonHref": "/decks/019de071-f0b8-737f-9ff6-e8b6f7a1e960.json",
  "deckAnchorHref": "/decks/019de071-f0b8-737f-9ff6-e8b6f7a1e960#slide-54",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.91,
        "x": 0.045,
        "y": 0.214
      },
      "kind": "list",
      "text": "23andMe has generated a research and development pipeline covering multiple therapeutic areas in indications of high unmet medical need\nTo date, more than 40 programs have been generated from the database as part of our collaboration with GSK\nGSK has extended their exclusive target discovery period of their collaboration with 23andMe for an additional fifth year\n23andMe advanced a novel immuno-oncology antibody targeting CD200R1, 23ME-00610, into the clinic\n23andMe has taken a royalty option on immuno-oncology antibody collaboration program targeting CD96 into later stages of development\nManaging our therapeutic portfolio investments based on scientific data to optimize investment, mitigate risk and maximize potential future returns",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea69f982-117f-48ce-b5a1-5293acb16b88",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.056,
        "w": 0.435,
        "x": 0.045,
        "y": 0.078
      },
      "kind": "title",
      "text": "Executive Summary - Therapeutics",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e06404af-8234-47d9-a461-09405bd0062b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 78,
      "from": 54,
      "beatId": "ede66bd1-b0b3-46d7-b470-71e7539d105e",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The presentation deck concludes with an executive summary and discussion of next steps",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}